Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-27 Sale |
2023-01-31 4:30 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
50,000 | $9.02 | $451,000 | 5,110,634 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 5:23 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
150,000 | $9.2533 | $1,388,000 | 5,160,634 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 6:20 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
155,000 | $9.1181 | $1,413,300 | 5,310,634 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:57 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
2,188 | $9.8487 | $21,549 | 112,775 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:55 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,106 | $9.8485 | $10,892 | 35,088 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:53 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
2,188 | $9.8487 | $21,549 | 51,903 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 6:26 pm |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
902,400 | $7.9148 | $7,142,343 | 3,851,507 (Indirect) |
View |
| 2023-01-06 Sale |
2023-01-10 4:07 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
388 | $6.41 | $2,487 | 36,194 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 4:15 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
349,972 | $6.1643 | $2,157,329 | 5,465,634 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 4:15 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
128,456 | $6.04 | $775,874 | 5,815,606 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 4:22 pm |
Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
483,815 | $6.0975 | $2,950,083 | 5,944,062 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-18 5:34 pm |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director |
9,512 | $6.7 | $63,730 | 21,788 (Indirect Direct) |
View |
| 2022-07-14 Sale |
2022-07-18 5:32 pm |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director |
13,891 | $6.7 | $93,070 | 31,314 (Direct) |
View |
| 2022-06-21 Purchase |
2022-06-23 5:21 pm |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
477,400 | $5.5761 | $2,662,047 | 4,753,907 (Indirect) |
View |
| 2022-04-04 Sale |
2022-04-06 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,527 | $8.25 | $12,598 | 52,060 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-06 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
2,786 | $8.25 | $22,985 | 114,963 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-23 6:40 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
4,413 | $8.2945 | $36,604 | 53,587 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-23 6:39 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
4,955 | $8.2946 | $41,100 | 117,749 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-23 6:36 pm |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
2,649 | $8.2946 | $21,972 | 52,458 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:37 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
4,100 | $3.55 | $14,555 | 122,704 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:35 pm |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
789 | $3.55 | $2,801 | 55,107 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 4:42 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
3,252 | $3.36 | $10,927 | 126,804 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 4:40 pm |
Voyager Therapeutics Inc. | VYGR | Burek Julie VP, Finance |
361 | $3.36 | $1,213 | 55,896 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-31 Option Award |
2023-01-10 4:07 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
388 | $5.17 | 36,194 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:55 pm |
N/A 2033-01-01 |
Voyager Therapeutics Inc. | VYGR | Colon Grace Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2022-10-01 Option Award |
2022-10-04 4:15 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-21 4:42 pm |
N/A 2032-09-19 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-21 4:41 pm |
N/A 2032-09-19 |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2022-09-21 4:39 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
0 | $0 | 210,120 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-16 5:03 pm |
N/A 2032-08-15 |
Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:38 pm |
N/A 2032-06-06 |
Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:37 pm |
N/A 2032-06-06 |
Voyager Therapeutics Inc. | VYGR | Hyman Steven Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:37 pm |
N/A 2032-06-06 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:36 pm |
N/A 2032-06-06 |
Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:35 pm |
N/A 2032-06-06 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director |
22,000 | $0 | 22,000 (Direct) |
View |
Ownership |
2022-04-25 9:30 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner |
0 | $0 | 4,276,507 (Indirect) |
View |
| 2022-03-22 Option Award |
2022-03-23 6:35 pm |
N/A 2032-03-22 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
1,040,600 | $0 | 1,040,600 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:28 pm |
N/A 2032-02-07 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
65,000 | $0 | 65,000 (Direct) |
View |